[BOOK][B] Scientists and the regulation of risk: Standardising control
D Demortain - 2011 - books.google.com
Risks are increasingly regulated by international standards, and scientists play a key role in
standardisation. This fascinating book exposes the action of'invisible colleges' of scientists …
standardisation. This fascinating book exposes the action of'invisible colleges' of scientists …
The application of hazard analysis and critical control points and risk management in the preparation of anti-cancer drugs
B Bonan, N Martelli, M Berhoune… - … Journal for Quality in …, 2009 - academic.oup.com
Abstract Objective To apply the Hazard Analysis and Critical Control Points method to the
preparation of anti-cancer drugs. To identify critical control points in our cancer …
preparation of anti-cancer drugs. To identify critical control points in our cancer …
[BOOK][B] Computer systems validation: quality assurance, risk management, and regulatory compliance for pharmaceutical and healthcare companies
G Wingate - 2003 - taylorfrancis.com
Both pervasive and ubiquitous, computerized systems are now an integral component of
every corporate strategy in pharmaceutical and healthcare companies. However, when …
every corporate strategy in pharmaceutical and healthcare companies. However, when …
Opportunities, challenges and benefits of using HACCP as a quality risk management tool in the pharmaceutical industry
Effective quality risk management can facilitate better and more informed decisions, provide
regulators with greater assurance of a company's ability to deal with potential risks and can …
regulators with greater assurance of a company's ability to deal with potential risks and can …
Pharmaceutical sterilization
AK Dhara, PK Bandyopadhyay, AK Nayak - Dosage Forms, Formulation …, 2024 - Elsevier
Pharmaceutical sterilization is the process that effectively kills or removes all forms of
microorganisms including bacteria, spores, and fungi from pharmaceutical preparations …
microorganisms including bacteria, spores, and fungi from pharmaceutical preparations …
The application of quality risk management to the bacterial endotoxins test: use of hazard analysis and critical control points
C Annalaura, D Giulia, C Stefano - PDA Journal of Pharmaceutical …, 2013 - journal.pda.org
Risk analysis is widely used in the pharmaceutical industry to manage production
processes, validation activities, training, and other activities. Several methods of risk …
processes, validation activities, training, and other activities. Several methods of risk …
[PDF][PDF] Cleanrooms and associated controlled environments-biocontamination control: dissecting the standard
T Sandle - 2022 - researchgate.net
In 2020 a new contamination control standard has been issued, specifically focusing on
biocontamination control, titled EN 17141: 2020 “Cleanrooms and associated controlled …
biocontamination control, titled EN 17141: 2020 “Cleanrooms and associated controlled …
A Model of Risk Analysis in Analytical Methodology for Biopharmaceutical Quality Control
CL Andrade, MADLO Herrera… - PDA Journal of …, 2018 - journal.pda.org
One key quality control parameter for biopharmaceutical products is the analysis of residual
cellular DNA. To determine small amounts of DNA (around 100 pg) that may be in a …
cellular DNA. To determine small amounts of DNA (around 100 pg) that may be in a …
[PDF][PDF] Compounding Practices
LA Trissel - International Journal of Pharmaceutical Compounding, 2003 - researchgate.net
Some industries have adopted different types of systems to ensure quality. These include
failure mode effect analysis (FMEA), root cause analysis and hazard analysis critical control …
failure mode effect analysis (FMEA), root cause analysis and hazard analysis critical control …
[PDF][PDF] Best Practices In Environmental Monitoring
T Sandle - rssl.com
The purpose of microbiological environmental monitoring is to assess the cleanliness of
pharmaceutical (sterile and non-sterile) and medical device manufacturing environments …
pharmaceutical (sterile and non-sterile) and medical device manufacturing environments …